MPO and neoplasm: Significantly higher MPO concentrations were detected in the sera of KCM tumor bearing mice treated with the combination of TAB004 + Lip-MSA-IL-2 than in the sera of the mice that were administered the other treatments (P < 0.001; Figure 4).